These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7448726)

  • 1. Estrogen receptor status and response to chemotherapy in advanced breast cancer.
    Kiang DT; Frenning DH; Gay J; Goldman AI; Kennedy BJ
    Cancer; 1980 Dec; 46(12 Suppl):2814-7. PubMed ID: 7448726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor status and response to polychemotherapy in advanced breast cancer.
    Jonat W; Maass H; Stolzenbach G; Trams G
    Cancer; 1980 Dec; 46(12 Suppl):2809-13. PubMed ID: 7004625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor status and response to chemotherapy in advanced breast cancer: the Tufts-Shattuck-Pondville experience.
    Rosenbaum C; Marsland TA; Stolbach LL; Raam S; Cohen JL
    Cancer; 1980 Dec; 46(12 Suppl):2919-21. PubMed ID: 7448736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptors and responsiveness of advanced breast cancer to chemotherapy.
    Samal BA; Brooks SC; Cummings G; Franco L; Hire EA; Martino S; Singhakowinta A; Vaitkevicius VK
    Cancer; 1980 Dec; 46(12 Suppl):2925-7. PubMed ID: 7004629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptors and responses to chemotherapy and hormonal therapy in advanced breast cancer.
    Kiang DT; Frenning DH; Goldman AI; Ascensao VF; Kennedy BJ
    N Engl J Med; 1978 Dec; 299(24):1330-4. PubMed ID: 714108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptors and response to endocrine therapy and cytotoxic chemotherapy in advanced breast cancer.
    Rubens RD; Hayward JL
    Cancer; 1980 Dec; 46(12 Suppl):2922-4. PubMed ID: 7448737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lack of relationship between estrogen receptor status and response to chemotherapy.
    Hilf R; Feldstein ML; Savlov ED; Gibson SL; Seneca B
    Cancer; 1980 Dec; 46(12 Suppl):2797-800. PubMed ID: 7448724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extramural review of clinical response of breast cancer to cytotoxic chemotherapy.
    Sears ME; Olson KB
    Cancer; 1980 Dec; 46(12 Suppl):2928-9. PubMed ID: 7448738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which patients with estrogen receptor-positive early breast cancer should be treated with adjuvant chemotherapy?
    Chiuri VE; Lorusso V
    Oncology; 2009; 77 Suppl 1():18-22. PubMed ID: 20130428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between steroid hormone receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC; Warren R
    Cancer Treat Rep; 1978 Sep; 62(9):1281-6. PubMed ID: 688273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of estrogen receptor status on response to combination chemotherapy for recurrent breast cancer.
    Mortimer J; Reimer R; Greenstreet R; Groppe C; Bukowski R
    Cancer Treat Rep; 1981; 65(9-10):763-6. PubMed ID: 7273011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oestrogen receptors and response to cytotoxic chemotherapy in advanced breast cancer.
    Rubens RD; King RJ; Sexton S; Minton MJ; Hayward JL
    Cancer Chemother Pharmacol; 1980; 4(1):43-5. PubMed ID: 7363400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of estrogen receptor and Ki-67 index after neoadjuvant chemotherapy in locally advanced breast cancer expressing high levels of proliferation at diagnosis.
    Miglietta L; Vanella P; Canobbio L; Naso C; Cerisola N; Meszaros P; Parodi MA; Morabito F
    Oncology; 2010; 79(3-4):255-61. PubMed ID: 21372600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The problem of nonresponding estrogen receptor-positive patients with advanced breast cancer.
    Maass H; Jonat W; Stolzenbach G; Trams G
    Cancer; 1980 Dec; 46(12 Suppl):2835-7. PubMed ID: 7470229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between steroid receptors and response to endocrine therapy and cytotoxic chemotherapy in metastatic breast cancer.
    Young PC; Ehrlich CE; Einhorn LH
    Cancer; 1980 Dec; 46(12 Suppl):2961-3. PubMed ID: 7448744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor status of advanced breast cancer immediately before chemotherapy does not predict for response.
    Stewart JF; Hayward JL; Rubens RD; King RJ
    Cancer Chemother Pharmacol; 1982; 9(2):124-5. PubMed ID: 7172407
    [No Abstract]   [Full Text] [Related]  

  • 17. Disease management patterns for postmenopausal women in Europe with hormone-receptor-positive, human epidermal growth factor receptor-2 negative advanced breast cancer.
    André F; Neven P; Marinsek N; Zhang J; Baladi JF; Degun R; Benelli G; Saletan S; Jerusalem G
    Curr Med Res Opin; 2014 Jun; 30(6):1007-16. PubMed ID: 24490834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone receptor and HER2 status: The only predictive factors of response to neoadjuvant chemotherapy in breast cancer.
    Baulies S; Cusidó M; González-Cao M; Tresserra F; Fargas F; Rodríguez I; Úbeda B; Ara C; Fábregas R
    J Obstet Gynaecol; 2015; 35(5):485-9. PubMed ID: 25383894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer.
    Lippman ME; Allegra JC; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC; Warren R
    N Engl J Med; 1978 Jun; 298(22):1223-8. PubMed ID: 651963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of estrogen receptor status in predicting the response of carcinoma of the breast to adjuvant chemotherapy.
    Stephens RB; Abeloff MD; Mellits ED; Baker RR
    Surg Gynecol Obstet; 1982 Feb; 154(2):200-4. PubMed ID: 6277024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.